William John Yaxley1,2, François-Xavier Nouhaud3,4, Sheliyan Raveenthiran5, Anthony Franklin2,6,7, Peter Donato4, Geoff Coughlin7, Boon Kua7, Troy Gianduzzo2,7, David Wong2,8, Robert Parkinson8, Nicholas Brown8, Hemamali Samaratunga2,9, Brett Delahunt10, Lars Egevad11, Matthew Roberts2,4, John William Yaxley12,13,14. 1. The Prince Charles Hospital, Brisbane, QLD, Australia. 2. University of Queensland, School of Medicine, Brisbane, QLD, Australia. 3. Rouen University Hospital, Rouen, France. 4. Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. 5. Wollongong Hospital, Wollongong, NSW, Australia. 6. Wesley Medical Research, Brisbane, QLD, Australia. 7. Wesley Hospital, Brisbane, QLD, Australia. 8. I-MED Radiology Network, Wesley Hospital, Brisbane, QLD, Australia. 9. Aquesta Uropathology, Brisbane, QLD, Australia. 10. Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand. 11. Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden. 12. University of Queensland, School of Medicine, Brisbane, QLD, Australia. dryaxley@wesleyurologyclinic.com.au. 13. Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. dryaxley@wesleyurologyclinic.com.au. 14. Wesley Hospital, Brisbane, QLD, Australia. dryaxley@wesleyurologyclinic.com.au.
Abstract
BACKGROUND: Prostate multiparametric magnetic resonance imaging (mpMRI) has become a popular initial investigation of an elevated PSA and is being incorporated into active surveillance protocols. Decisions on prostate cancer investigation and management based solely on a normal mpMRI remains controversial. Histopathological findings of a totally embedded normal mpMRI lobe are rarely described. METHODS: A retrospective review of the histological findings of negative preoperative mpMRI lobes in men treated by robot assisted laparoscopic radical prostatectomy (RALP). Inclusion criteria included a preoperative low risk mpMRI for both lobes (Prostate Imaging-Reporting and Data System (PIRADS) ≤ 2) or one negative lobe (with a PIRADS 3-5 in the opposite lobe). RESULTS: A single normal mpMRI lobe was identified in 1018 men (PIRADS 3-5 group). Both lobes were normal in 179 men (PIRADS ≤ 2 group). Prostate cancer was identified in 47.6% (485/1018) of the normal mpMRI lobe opposite a PIRADS 3-5 lesion, including 13.2% (134/1018) with >0.5 cc of International Society of Urologic Pathologists (ISUP) grade 2, or a higher grade cancer. ISUP grade 4-5 was only identified in 2% (20/1018). Compared to RALP histology of the PIRADS 3-5 mpMRI tumour, a pathological ISUP upgrade in the normal mpMRI lobe was identified in 58/1018 men (5.7%). In the PIRADS ≤ 2 group extraprostatic extension occurred in 19% (34/179) and seminal vesicle invasion (pT3b) in 3.9% (7/179). There was no difference in margin status between the PIRADS 3-5 and ≤2 groups (p = 0.247). CONCLUSIONS: mpMRI underestimates tumour grade and volume compared to totally embedded histopathological analysis of RALP specimens, although ISUP grade 4-5 cancer is uncommon. Our analysis provides useful insight into the multifocality of prostate cancers, and highlights the utility of systematic biopsy, in addition to targeted biopsies. These results have ramifications for clinical decisions on prostate cancer management based solely on the mpMRI appearance, including active surveillance.
BACKGROUND: Prostate multiparametric magnetic resonance imaging (mpMRI) has become a popular initial investigation of an elevated PSA and is being incorporated into active surveillance protocols. Decisions on prostate cancer investigation and management based solely on a normal mpMRI remains controversial. Histopathological findings of a totally embedded normal mpMRI lobe are rarely described. METHODS: A retrospective review of the histological findings of negative preoperative mpMRI lobes in men treated by robot assisted laparoscopic radical prostatectomy (RALP). Inclusion criteria included a preoperative low risk mpMRI for both lobes (Prostate Imaging-Reporting and Data System (PIRADS) ≤ 2) or one negative lobe (with a PIRADS 3-5 in the opposite lobe). RESULTS: A single normal mpMRI lobe was identified in 1018 men (PIRADS 3-5 group). Both lobes were normal in 179 men (PIRADS ≤ 2 group). Prostate cancer was identified in 47.6% (485/1018) of the normal mpMRI lobe opposite a PIRADS 3-5 lesion, including 13.2% (134/1018) with >0.5 cc of International Society of Urologic Pathologists (ISUP) grade 2, or a higher grade cancer. ISUP grade 4-5 was only identified in 2% (20/1018). Compared to RALP histology of the PIRADS 3-5 mpMRI tumour, a pathological ISUP upgrade in the normal mpMRI lobe was identified in 58/1018 men (5.7%). In the PIRADS ≤ 2 group extraprostatic extension occurred in 19% (34/179) and seminal vesicle invasion (pT3b) in 3.9% (7/179). There was no difference in margin status between the PIRADS 3-5 and ≤2 groups (p = 0.247). CONCLUSIONS: mpMRI underestimates tumour grade and volume compared to totally embedded histopathological analysis of RALP specimens, although ISUP grade 4-5 cancer is uncommon. Our analysis provides useful insight into the multifocality of prostate cancers, and highlights the utility of systematic biopsy, in addition to targeted biopsies. These results have ramifications for clinical decisions on prostate cancer management based solely on the mpMRI appearance, including active surveillance.
Authors: Gregory T Chesnut; Emily A Vertosick; Nicole Benfante; Daniel D Sjoberg; Jonathan Fainberg; Taehyoung Lee; James Eastham; Vincent Laudone; Peter Scardino; Karim Touijer; Andrew Vickers; Behfar Ehdaie Journal: Eur Urol Date: 2019-12-23 Impact factor: 20.096
Authors: John R Srigley; Brett Delahunt; Lars Egevad; Hemamali Samaratunga; John Yaxley; Andrew J Evans Journal: Can Urol Assoc J Date: 2016 Sep-Oct Impact factor: 1.862
Authors: Laurence Klotz; Greg Pond; Andrew Loblaw; Linda Sugar; Madeline Moussa; David Berman; Theo Van der Kwast; Danny Vesprini; Laurent Milot; Marlene Kebabdjian; Neil Fleshner; Sangheet Ghai; Joseph Chin; Masoom Haider Journal: Eur Urol Date: 2019-11-08 Impact factor: 20.096
Authors: Peter Donato; Andrew Morton; John Yaxley; Patrick E Teloken; Geoff Coughlin; Rachel Esler; Nigel Dunglison; Robert A Gardiner; Matthew J Roberts Journal: World J Urol Date: 2019-05-04 Impact factor: 4.226
Authors: Robert R Flavell; Antonio C Westphalen; Carmin Liang; Christopher C Sotto; Susan M Noworolski; Daniel B Vigneron; Zhen J Wang; John Kurhanewicz Journal: Abdom Imaging Date: 2014-10
Authors: Jim C Hu; Edward Chang; Shyam Natarajan; Daniel J Margolis; Malu Macairan; Patricia Lieu; Jiaoti Huang; Geoffrey Sonn; Frederick J Dorey; Leonard S Marks Journal: J Urol Date: 2014-02-08 Impact factor: 7.450
Authors: Fredrik Jäderling; Olof Akre; Markus Aly; Johan Björklund; Mats Olsson; Christofer Adding; Michael Öberg; Lennart Blomqvist; Tommy Nyberg; Peter Wiklund; Stefan Carlsson Journal: Prostate Cancer Prostatic Dis Date: 2018-11-30 Impact factor: 5.554
Authors: Kevin Michael Gallagher; Edward Christopher; Andrew James Cameron; Scott Little; Alasdair Innes; Gill Davis; Julian Keanie; Prasad Bollina; Alan McNeill Journal: BJU Int Date: 2018-10-09 Impact factor: 5.588